F Saeed, M Afzaal, B Niaz, MU Arshad… - … Journal of Food …, 2018 - Taylor & Francis
Bitter melon provides health benefits against various ailments for improving the quality of life. It is nutrient dense plant-based food containing versatility of bioactive compounds such …
F Cai, J Li, Y Zhang, S Huang, W Liu, W Zhuo, C Qiu - BMC cancer, 2024 - Springer
Background Targeted drugs are the main methods of RCC treatment. However, drug resistance is common in RCC patients, in-depth study of the drug-resistant mechanism is …
Y Zhou, J Jin, M Feng, D Zhu - Current Protein and Peptide …, 2019 - ingentaconnect.com
Inflammation is the first response occurring after damage or infection, which is a defensive process for the body. It is well known that excessive inflammation can lead to further …
HM Xi, H Lu, XQ Weng, Y Sheng, J Wu… - Anti-Cancer Agents in …, 2023 - ingentaconnect.com
Background and Objective: All-trans retinoic acid (ATRA) is only effective in acute promyelocytic leukemia (APL), but not in other subtype of acute myeloid leukemia (AML) …
X Wang, X Wang - Oncology Letters, 2019 - spandidos-publications.com
The aim of this study was to investigate how long non‑coding (lnc) RNA colon cancer‑ associated transcript 2 (CCAT2) regulates the proliferation, invasion and metastasis of …
Acute myeloid leukemia (AML) is a malignant clonal disorder affecting myeloid differentiation through mechanisms that include epigenetic dysregulation. Abnormal …
LM Kroschwald, JT Tauer… - Oncology …, 2019 - spandidos-publications.com
Tyrosine kinase inhibitors (TKIs), such as imatinib (IMA) and nilotinib (NIL), are the cornerstone of chronic myeloid leukemia (CML) treatment via the blockade of the oncogenic …
Numerous recurrent genetic mutations are known to occur in acute myeloid leukemia (AML). Among these common mutations, Fms-like tyrosine kinase 3 remains as one of the most …